Treatment of Central Sleep Apnea Syndromes
نویسندگان
چکیده
منابع مشابه
Obstructive sleep apnea syndromes.
The first description of an obstructive sleep apnea (OSA) sufferer is generally attributed to the novelist Charles Dickens, who described ‘‘Joe’’ in The Posthumous Papers of the Pickwick Club, published in 1836. Joe was an excessively sleepy, obese boy who snored loudly and had possible right-sided heart failure that led to his being called ‘‘young dropsy’’ [1,2]. The first physician to describ...
متن کاملSleep apnea and heart failure: Part II: central sleep apnea.
In the first part of this 2-part review, we provided a synopsis of the cardiovascular effects of normal sleep and an overview of the diagnostic, pathophysiological, and therapeutic implications of obstructive sleep apnea (OSA) in the setting of heart failure (HF). In this second part, we turn our attention to central sleep apnea (CSA), commonly referred to as Cheyne-Stokes respiration. This bre...
متن کاملSuccessful treatment of central sleep apnea with an oral prosthesis.
Two cases of polygraphically defined central sleep apnea were successfully treated with the tongue retaining device, an oral prosthesis designed to reduce hypopharyngeal obstruction. The tongue retaining device may be an alternative to CPAP in the treatment of some cases of central sleep apnea.
متن کاملPhrenic nerve stimulation for the treatment of central sleep apnea.
OBJECTIVES The aim of this study was to evaluate chronic, transvenous, unilateral phrenic nerve stimulation to treat central sleep apnea (CSA) in a prospective, multicenter, nonrandomized study. BACKGROUND CSA occurs predominantly in patients with heart failure and increases the risk for morbidity and mortality. Established therapies for CSA are lacking, and those available are limited by poo...
متن کاملTreatment of Central Sleep Apnea Syndrome in Adults
The AASM has made an important update to the recommendation regarding use of adaptive servo-ventilation (ASV) for treatment of central sleep apnea syndromes (CSAS) related to chronic heart failure (CHF). This update stems from the May 2015 ResMed Field Safety Notice indicating that patients with symptomatic CHF and reduced left ventricular ejection fraction (LVEF ≤45%) using ASV for treatment o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sleep
سال: 2012
ISSN: 0161-8105,1550-9109
DOI: 10.5665/sleep.2068